NCT04260802 2026-01-12A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersOcellaris Pharma, Inc.Phase 1/2 Terminated73 enrolled
NCT04954599 2025-10-07Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIMaastricht University Medical CenterPhase 1/2 Recruiting126 enrolled
NCT03387085 2024-08-09QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.ImmunityBio, Inc.Phase 1/2 Terminated9 enrolled 18 charts
NCT04551885 2023-09-21FT516 in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated12 enrolled
NCT02222922 2020-12-17A Study Of PF-06647020 For Adult Patients With Advanced Solid TumorsPfizerPhase 1 Completed138 enrolled 98 charts